Food and Drug Administration

FDA approves generic drug for a rare genetic condition

FDA approves generic drug for a rare genetic condition, but not for autism

The Food and Drug Administration on Tuesday approved a long-available generic drug called leucovorin for use against a rare disorder that causes autism-like symptoms.

· 2d · on MSN

FDA approves leucovorin as first drug for rare genetic disorder, after touting it as autism treatment

· 2d

FDA finds little evidence that a drug touted by Trump can help people with autism

· 1d

FDA won’t endorse Leucovorin for autism

The FDA expanded the use of prescription drug Leucovorin, but said it won’t recommend it for autism.

· 1d

FDA OKs drug for rare brain disorder

· 1d

RFK Jr.’s Autism Drug Claims Face Pushback From FDA — Report

FOX 4 News Dallas-Fort Worth

Raw oysters and clams recalled in 9 states over potential norovirus contamination, FDA says

The Food and Drug Administration said the recall involves certain clams and oysters distributed in nine states, including California, Georgia, and Florida.

MyTwinTiers.com on MSN

Viagra drug found in 'wellness' supplement prompts nationwide recall

A New Mexico-based company is recalling one of its supplements after a lab found it to contain the erectile dysfunction drug sildenafil, according to a Wednesday news release from the Food and Drug Administration (FDA).

1don MSN

US FDA launches unified platform to report drug side effects

March 11 (Reuters) - The U.S. Food and Drug Administration said on Wednesday it has introduced a unified platform designed to streamline the analysis of reports on drug side effects. * The new platform,

FDA launches new AI-powered system to track drug and vaccine side effects nationwide

FDA launches new AI-powered system to track drug and vaccine side effects in real time, replacing outdated databases and saving $120 million annually.

2don MSN

Oysters and clams in 9 states could be contaminated with norovirus, FDA warns

The FDA on Monday warned consumers about oysters and clams which could be contaminated with norovirus and were sent to nine states, including California, Florida and New York

3don MSN

FDA Plans to Loosen Testing Rules to Boost Biosimilar Drugs

The US Food and Drug Administration is easing some requirements for drugmakers developing copycat versions of costly biologic medications in a bid to bring more competition to the market and lower costs.

14d

FDA to offer bonus payments to staffers who complete speedy drug reviews

The head of the Food and Drug Administration plans to start offering bonus payments to agency drug reviewers who complete their work ahead of the schedule.